Market Research Logo

Rheumatoid - Inflammatory Diseases Markers Tests - Medical Devices Pipeline Assessment, 2017

Rheumatoid - Inflammatory Diseases Markers Tests - Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, “Rheumatoid - Inflammatory Diseases Markers Tests - Medical Devices Pipeline Assessment, 2017 provides an overview of Rheumatoid - Inflammatory Diseases Markers Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Rheumatoid - Inflammatory Diseases Markers Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Rheumatoid - Inflammatory Diseases Markers Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Rheumatoid - Inflammatory Diseases Markers Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Rheumatoid - Inflammatory Diseases Markers Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Rheumatoid - Inflammatory Diseases Markers Tests Overview
3 Products under Development
3.1 Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Stage of Development
3.2 Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Segment
3.3 Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Territory
3.4 Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Regulatory Path
3.5 Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Estimated Approval Date
4 Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products under Development by Companies
4.1 Rheumatoid - Inflammatory Diseases Markers Tests Companies - Pipeline Products by Stage of Development
4.2 Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Stage of Development
5 Rheumatoid - Inflammatory Diseases Markers Tests Companies and Product Overview
5.1 Abcodia Ltd Company Overview
5.1.1 Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.2 Albert Ludwigs University of Freiburg Company Overview
5.2.1 Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview
5.3 Analyticon Biotechnologies AG Company Overview
5.3.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
5.4 AnaMar AB Company Overview
5.4.1 AnaMar AB Pipeline Products & Ongoing Clinical Trials Overview
5.5 Arizona State University Company Overview
5.5.1 Arizona State University Pipeline Products & Ongoing Clinical Trials Overview
5.6 AXO Science SAS Company Overview
5.6.1 AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview
5.7 Bayerische Patentallianz GmbH Company Overview
5.7.1 Bayerische Patentallianz GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.8 Beckman Coulter Inc Company Overview
5.8.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 BioSIMS Company Overview
5.9.1 BioSIMS Pipeline Products & Ongoing Clinical Trials Overview
5.10 Boditech Med Inc Company Overview
5.10.1 Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 CD Diagnostics, Inc. Company Overview
5.11.1 CD Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.12 CDI Laboratories Inc Company Overview
5.12.1 CDI Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
5.13 Chronix Biomedical Inc Company Overview
5.13.1 Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 Consejo Superior de Investigaciones Cientificas Company Overview
5.14.1 Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview
5.15 DxTerity Diagnostics Inc Company Overview
5.15.1 DxTerity Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 EKF Diagnostics Holdings Plc Company Overview
5.16.1 EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview
5.17 EMD Millipore Corp Company Overview
5.17.1 EMD Millipore Corp Pipeline Products & Ongoing Clinical Trials Overview
5.18 Epinex Diagnostics Inc Company Overview
5.18.1 Epinex Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.19 Firalis SAS Company Overview
5.19.1 Firalis SAS Pipeline Products & Ongoing Clinical Trials Overview
5.20 French National Institute of Health and Medical Research Company Overview
5.20.1 French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview
5.21 Fundacio Clinic per a la Recerca Biomedica Company Overview
5.21.1 Fundacio Clinic per a la Recerca Biomedica Pipeline Products & Ongoing Clinical Trials Overview
5.22 Genalyte, Inc. Company Overview
5.22.1 Genalyte, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.23 GeneNews Ltd Company Overview
5.23.1 GeneNews Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.24 Ghent University Company Overview
5.24.1 Ghent University Pipeline Products & Ongoing Clinical Trials Overview
5.25 Ignyta Inc Company Overview
5.25.1 Ignyta Inc Pipeline Products & Ongoing Clinical Trials Overview
5.26 Iquity Labs Inc Company Overview
5.26.1 Iquity Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
5.27 John Hopkins University Company Overview
5.27.1 John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
5.28 KineMed Inc Company Overview
5.28.1 KineMed Inc Pipeline Products & Ongoing Clinical Trials Overview
5.29 LifeAssays AB Company Overview
5.29.1 LifeAssays AB Pipeline Products & Ongoing Clinical Trials Overview
5.30 Louisville Bioscience, Inc. Company Overview
5.30.1 Louisville Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.31 Medica Corp Company Overview
5.31.1 Medica Corp Pipeline Products & Ongoing Clinical Trials Overview
5.32 Myriad Genetics Inc Company Overview
5.32.1 Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.33 Proplex Technologies Llc Company Overview
5.33.1 Proplex Technologies Llc Pipeline Products & Ongoing Clinical Trials Overview
5.34 Protagen AG Company Overview
5.34.1 Protagen AG Pipeline Products & Ongoing Clinical Trials Overview
5.35 Queen Mary University of London Company Overview
5.35.1 Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview
5.36 Research & Diagnostic Antibodies LLC Company Overview
5.36.1 Research & Diagnostic Antibodies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.37 Selventa Inc Company Overview
5.37.1 Selventa Inc Pipeline Products & Ongoing Clinical Trials Overview
5.38 SomaLogic Inc Company Overview
5.38.1 SomaLogic Inc Pipeline Products & Ongoing Clinical Trials Overview
5.39 SQI Diagnostics Inc Company Overview
5.39.1 SQI Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.40 The Binding Site Group Ltd Company Overview
5.40.1 The Binding Site Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.41 Thermo Fisher Scientific Inc Company Overview
5.41.1 Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview
5.42 Toscana Biomarkers Srl Company Overview
5.42.1 Toscana Biomarkers Srl Pipeline Products & Ongoing Clinical Trials Overview
5.43 University Health Network Company Overview
5.43.1 University Health Network Pipeline Products & Ongoing Clinical Trials Overview
5.44 University of Aberdeen Company Overview
5.44.1 University of Aberdeen Pipeline Products & Ongoing Clinical Trials Overview
5.45 University of Manchester Company Overview
5.45.1 University of Manchester Pipeline Products & Ongoing Clinical Trials Overview
5.46 University of Oxford Company Overview
5.46.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
5.47 University of Rochester Company Overview
5.47.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
5.48 University of Warwick Company Overview
5.48.1 University of Warwick Pipeline Products & Ongoing Clinical Trials Overview
5.49 University Rovira i Virgili Company Overview
5.49.1 University Rovira i Virgili Pipeline Products & Ongoing Clinical Trials Overview
6 Rheumatoid - Inflammatory Diseases Markers Tests- Recent Developments
6.1 Aug 24, 2017: SQI Diagnostics Reports Third Quarter 2017 Results
6.2 Aug 22, 2017: Volition Signs Agreement with the Institute of Laboratory Medicine of the Technical University of Munich, Germany, to assist in securing large trials in a range of cancers
6.3 Aug 15, 2017: GeneNews Announces Q2-2017 Financial Results & Provides Progress Update
6.4 Aug 09, 2017: VolitionRx Announces Second Quarter 2017 Financial Results and Business Update
6.5 Aug 03, 2017: Alere Reports Second Quarter 2017 Financial Results
6.6 Aug 03, 2017: Bio-Rad Reports Second-Quarter 2017 Financial Results
6.7 Jul 26, 2017: Thermo Fisher Scientific Reports Second Quarter 2017 Results
6.8 Jul 25, 2017: Theradiag: Further Strong Sales Growth in the First Half of 2017: +9%
6.9 Jul 13, 2017: Dr. Jaymie Sawyer, Vice President of R&D, Transitions to Lead Scientific Advisory Committee
6.10 Jun 30, 2017: GeneNews Announces Election of Directors
6.11 Jun 29, 2017: HYCOR Biomedical Announces Senior Level Appointments to Management Team
6.12 Jun 15, 2017: Crescendo Bioscience Announces Results from a Meta-Analysis of Studies with Vectra DA at the 2017 Annual European Congress of Rheumatology
6.13 Jun 14, 2017: Alere Reports First Quarter 2017 Financial Results
6.14 Jun 08, 2017: Crescendo Bioscience Announces Six Studies with Vectra DA Will Be Presented at the 2017 Annual European Congress of Rheumatology
6.15 Jun 05, 2017: Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2016 Financial Results
6.16 May 22, 2017: Alere Provides Preliminary Unaudited Financial Results
6.17 May 11, 2017: VolitionRx Announces First Quarter 2017 Financial Results and Business Update
6.18 May 11, 2017: GeneNews Announces Q1-2017 Financial Results & Provides Progress Update
6.19 May 10, 2017: SQI Diagnostics Reports Second Quarter 2017 Results
6.20 May 04, 2017: Bio-Rad Reports First-Quarter 2017 Financial Results
6.21 May 02, 2017: Myriad Genetics Reports Fiscal Third-Quarter 2017 Financial Results
6.22 May 01, 2017: Ignyta Announces First Quarter 2017 Company Highlights and Financial Results
6.23 Apr 27, 2017: THERADIAG Announces First-quarter 2017 Revenues
6.24 Apr 27, 2017: Theradiag: First-Quarter 2017 Revenues
6.25 Apr 26, 2017: Thermo Fisher Scientific Reports First Quarter 2017 Results
6.26 Apr 24, 2017: Seno Medical Instruments Appoints Ann Waterhouse as VP, Quality Assurance and Regulatory Affairs
6.27 Apr 11, 2017: VolitionRx Appoints David Vanston as Chief Financial Officer
6.28 Apr 05, 2017: SomaLogic announces the appointment of long-time Board member as Chief Executive Officer
6.29 Apr 03, 2017: GeneNews Announces Fourth Quarter and Full Year 2016 Financial Results
6.30 Mar 20, 2017: EKF Diagnostics Holdings: Final results
6.31 Mar 14, 2017: Ignyta Announces Full Year 2016 Company Highlights and Financial Results
6.32 Mar 13, 2017: Bio-Rad Intends to Propose Three New Independent Directors
6.33 Mar 13, 2017: Bio-Rad Initiates Long Term Financial Guidance; Commits to Defining Long Term Capital Allocation Targets and Hosting an Annual Investor Day
6.34 Mar 10, 2017: VolitionRx Announces Full Fiscal Year 2016 Financial Results and Business Update
6.35 Mar 09, 2017: Alere Provides Update on Arriva Medical
6.36 Mar 01, 2017: Thermo Fisher Scientific Elects New Director to Board
6.37 Mar 01, 2017: Appointment of Dominique Costantini and Dominique Takizawa to Theradiag’s Board of Directors
6.38 Mar 01, 2017: THERADIAG: Full-year 2016 results
6.39 Feb 23, 2017: Ablynx Announces 2016 Full Year Results
6.40 Feb 23, 2017: VBio-Rad Reports Fourth-Quarter and Full-Year 2016 Financial Results
6.41 Feb 23, 2017: Bio-Rad Reports Fourth-Quarter and Full-Year 2016 Financial Results
6.42 Feb 21, 2017: SQI Diagnostics Reports First Quarter 2017 Results
6.43 Feb 07, 2017: Myriad Genetics Reports Fiscal Second-Quarter 2017 Financial Results
6.44 Jan 31, 2017: Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2016 Results
6.45 Jan 23, 2017: ISO 17025 Accreditation for Microbiology Manufacturing Site Offers Increased Confidence to Microbiology Testing Laboratories
6.46 Jan 18, 2017: SQI Diagnostics Announces Change to its Board of Directors
6.47 Jan 05, 2017: Metabolon to Work With InnVentis to Study Chronic Inflammatory Diseases
6.48 Jan 04, 2017: Alere Laboratory Receives ABFT Accreditation
6.49 Jan 04, 2017: Alere Provides Update on Arriva Medical
6.50 Dec 28, 2016: Alere Provides Update on Arriva Medical
6.51 Dec 27, 2016: Positive Clinical Utility Results of Crescendo’s Vectra DA Test for Rheumatoid Arthritis Published in the Journal Arthritis & Rheumatology
6.52 Dec 22, 2016: United Rheumatology Issues Clinical Practice Guidelines and Recommends the Vectra DA Test for Adults with Rheumatoid Arthritis
6.53 Dec 20, 2016: Singulex Opens European Office and Advances IVD System Evaluation
6.54 Dec 14, 2016: Beckman Coulter appoints IT Product Manager for Northern Europe
6.55 Dec 12, 2016: Ignyta appoints new board member
6.56 Dec 12, 2016: Ignyta Appoints Steven L. Hoerter, Chief Commercial Officer of Agios Pharmaceuticals to Board of Directors
6.57 Dec 08, 2016: Khang & Khang Announces Securities Class Action Lawsuit against Alere and Reminds Investors with Losses to Contact the Firm
6.58 Dec 07, 2016: IQuity appoints new board member
6.59 Dec 07, 2016: Abbott Seeks To Terminate Alere Acquisition
6.60 Nov 23, 2016: Ablynx Announces Results For The First Nine Months Of 2016 And A Year-To-Date Business Update
6.61 Nov 12, 2016: Crescendo Bioscience Announces Four Studies with Vectra DA Will Be Presented at the American College of Rheumatology 2016 Annual Meeting
6.62 Nov 11, 2016: GeneNews Announces Q3-2016 Financial Results and Provides Corporate Update
6.63 Nov 10, 2016: VolitionRx Announces Third Quarter 2016 Financial Results and Business Update
6.64 Nov 07, 2016: Ignyta Announces Third Quarter 2016 Company Highlights and Financial Results
6.65 Nov 04, 2016: Alere Reports Third Quarter 2016 Financial Results
6.66 Nov 01, 2016: Bio-Rad Reports Third-Quarter Currency-Neutral Revenue Growth of 9.1 Percent
6.67 Nov 01, 2016: Myriad Genetics Reports Fiscal First-Quarter 2017 Financial Results
6.68 Oct 27, 2016: Thermo Fisher Scientific Reports Third Quarter 2016 Results
6.69 Oct 13, 2016: THERADIAG: Very strong revenue growth at end-September 2016: +31%
6.70 Sep 29, 2016: Myriad Appoints Chip Parkinson as EVP for Reimbursement Strategy
6.71 Sep 14, 2016: THERADIAG: First-half 2016 Revenues and Results
6.72 Sep 14, 2016: Ignyta to Present at 2016 Silicon Valley Bank Healthcare Capital and Connections Summit
6.73 Sep 12, 2016: EKF Diagnostics Holdings: Half-year Report
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Stage of Development
Table 2: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Segment
Table 3: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Territory
Table 4: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Regulatory Path
Table 5: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Estimated Approval Date
Table 6: Rheumatoid - Inflammatory Diseases Markers Tests Companies - Pipeline Products by Stage of Development
Table 7: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Stage of Development
Table 8: Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Molecular Biomarker - Rheumatoid Arthritis - Product Status
Table 10: Molecular Biomarker - Rheumatoid Arthritis - Product Description
Table 11: Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Diagnostic Kit - Rheumatoid Arthritis - Product Status
Table 13: Diagnostic Kit - Rheumatoid Arthritis - Product Description
Table 14: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Turbitex ASL - Product Status
Table 16: Turbitex ASL - Product Description
Table 17: AnaMar AB Pipeline Products & Ongoing Clinical Trials Overview
Table 18: NeoSix Biomarker Assay - Product Status
Table 19: NeoSix Biomarker Assay - Product Description
Table 20: Arizona State University Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Diagnostic Test - Rheumatoid Arthritis - Product Status
Table 22: Diagnostic Test - Rheumatoid Arthritis - Product Description
Table 23: AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Multiplexed Detection - CRP - Product Status
Table 25: Multiplexed Detection - CRP - Product Description
Table 26: Bayerische Patentallianz GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Prognostic Test - Rheumatoid Arthritis - Product Status
Table 28: Prognostic Test - Rheumatoid Arthritis - Product Description
Table 29: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 30: AU480 Clinical System - anti-CCP Assay - Product Status
Table 31: AU480 Clinical System - anti-CCP Assay - Product Description
Table 32: AU5810 Clinical System - anti-CCP Assay - Product Status
Table 33: AU5810 Clinical System - anti-CCP Assay - Product Description
Table 34: AU5820 Clinical System - anti-CCP Assay - Product Status
Table 35: AU5820 Clinical System - anti-CCP Assay - Product Description
Table 36: AU5830 Clinical System - anti-CCP Assay - Product Status
Table 37: AU5830 Clinical System - anti-CCP Assay - Product Description
Table 38: AU5840 Clinical System - anti-CCP Assay - Product Status
Table 39: AU5840 Clinical System - anti-CCP Assay - Product Description
Table 40: AU680 Clinical System - anti-CCP Assay - Product Status
Table 41: AU680 Clinical System - anti-CCP Assay - Product Description
Table 42: UniCel DxC 600 - anti-CCP Assay - Product Status
Table 43: UniCel DxC 600 - anti-CCP Assay - Product Description
Table 44: UniCel DxC 600i Synchron Access - anti-CCP Assay - Product Status
Table 45: UniCel DxC 600i Synchron Access - anti-CCP Assay - Product Description
Table 46: UniCel DxC 680i Synchron Access Clinical System - anti-CCP Assay - Product Status
Table 47: UniCel DxC 680i Synchron Access Clinical System - anti-CCP Assay - Product Description
Table 48: UniCel DxC 800 Synchron Access Clinical System - anti-CCP Assay - Product Status
Table 49: UniCel DxC 800 Synchron Access Clinical System - anti-CCP Assay - Product Description
Table 50: UniCel DxC 860i Synchron Access Clinical System - anti-CCP Assay - Product Status
Table 51: UniCel DxC 860i Synchron Access Clinical System - anti-CCP Assay - Product Description
Table 52: UniCel DxC 880i Synchron Access Clinical System - anti-CCP Assay - Product Status
Table 53: UniCel DxC 880i Synchron Access Clinical System - anti-CCP Assay - Product Description
Table 54: BioSIMS Pipeline Products & Ongoing Clinical Trials Overview
Table 55: DigiPLEX Analyzer - Rheumatology Assay - Product Status
Table 56: DigiPLEX Analyzer - Rheumatology Assay - Product Description
Table 57: Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 58: AFIAS-6 RF IgM Assay - Product Status
Table 59: AFIAS-6 RF IgM Assay - Product Description
Table 60: CD Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 61: Cygnasure Diagnostic Immunoassay - Rheumatoid Arthritis - Product Status
Table 62: Cygnasure Diagnostic Immunoassay - Rheumatoid Arthritis - Product Description
Table 63: CDI Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 64: Diagnostic Test - Rheumatoid Arthritis - Product Status
Table 65: Diagnostic Test - Rheumatoid Arthritis - Product Description
Table 66: Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 67: Companion Diagnostic Test - Rheumatoid Arthritis - Product Status
Table 68: Companion Diagnostic Test - Rheumatoid Arthritis - Product Description
Table 69: Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview
Table 70: Diagnostic Assay - Rheumatoid Arthritis - Product Status
Table 71: Diagnostic Assay - Rheumatoid Arthritis - Product Description
Table 72: DxTerity Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 73: RADx - Product Status
Table 74: RADx - Product Description
Table 75: EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 76: Quo-Lab - C-Reactive Protein - Product Status
Table 77: Quo-Lab - C-Reactive Protein - Product Description
Table 78: EMD Millipore Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 79: Erenna System - Rheumatoid Arthritis - Product Status
Table 80: Erenna System - Rheumatoid Arthritis - Product Description
Table 81: Epinex Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 82: Epinex G1A - Rheumatoid Arthritis Rapid Diagnostic Test - Product Status
Table 83: Epinex G1A - Rheumatoid Arthritis Rapid Diagnostic Test - Product Description
Table 84: Firalis SAS Pipeline Products & Ongoing Clinical Trials Overview
Table 85: Biomarker Test - Rheumatoid Arthritis - Product Status
Table 86: Biomarker Test - Rheumatoid Arthritis - Product Description
Table 87: French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview
Table 88: GPI Biomarker Assay - Arthritis - Product Status
Table 89: GPI Biomarker Assay - Arthritis - Product Description
Table 90: Fundacio Clinic per a la Recerca Biomedica Pipeline Products & Ongoing Clinical Trials Overview
Table 91: Diagnostic Assay - Rheumatoid Arthritis - Product Status
Table 92: Diagnostic Assay - Rheumatoid Arthritis - Product Description
Table 93: Early Diagnostic Assay - Rheumatoid Arthritis - Product Status
Table 94: Early Diagnostic Assay - Rheumatoid Arthritis - Product Description
Table 95: Genalyte, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 96: Maverick Rheumatoid Arthritis Multiplex Assay Kit - Product Status
Table 97: Maverick Rheumatoid Arthritis Multiplex Assay Kit - Product Description
Table 98: GeneNews Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 99: Biomarker Diagnostic Test - Rheumatoid Arthritis - Product Status
Table 100: Biomarker Diagnostic Test - Rheumatoid Arthritis - Product Description
Table 101: Ghent University Pipeline Products & Ongoing Clinical Trials Overview
Table 102: Biomarker Test - Spondyloarthropathy - Product Status
Table 103: Biomarker Test - Spondyloarthropathy - Product Description
Table 104: Ignyta Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 105: CLIA Waived Diagnostic Test - Rheumatoid Arthritis - Product Status
Table 106: CLIA Waived Diagnostic Test - Rheumatoid Arthritis - Product Description
Table 107: TrailblazeDx Test - Rheumatoid Arthritis - Product Status
Table 108: TrailblazeDx Test - Rheumatoid Arthritis - Product Description
Table 109: TrailblazeTx Test - Rheumatoid Arthritis - Product Status
Table 110: TrailblazeTx Test - Rheumatoid Arthritis - Product Description
Table 111: Iquity Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 112: IsolateRheum - Product Status
Table 113: IsolateRheum - Product Description
Table 114: John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
Table 115: Anti-PAD3 Based Diagnostic Assay - Rheumatoid Arthritis - Product Status
Table 116: Anti-PAD3 Based Diagnostic Assay - Rheumatoid Arthritis - Product Description
Table 117: Biomarker Assay - Rheumatoid Arthritis - Product Status
Table 118: Biomarker Assay - Rheumatoid Arthritis - Product Description
Table 119: KineMed Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 120: Diagnostic Assay - Collagen Synthesis - Product Status
Table 121: Diagnostic Assay - Collagen Synthesis - Product Description
Table 122: LifeAssays AB Pipeline Products & Ongoing Clinical Trials Overview
Table 123: LifeAssays hsCRP - Product Status
Table 124: LifeAssays hsCRP - Product Description
Table 125: Louisville Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 126: Rheumatoid Arthritis pT Autoimmune Test - Product Status
Table 127: Rheumatoid Arthritis pT Autoimmune Test - Product Description
Table 128: Medica Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 129: EasyRA Analyzer - RF Assay - Product Status
Table 130: EasyRA Analyzer - RF Assay - Product Description
Table 131: Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 132: myPath Psoriatic Arthritis - Product Status
Table 133: myPath Psoriatic Arthritis - Product Description
Table 134: Proplex Technologies Llc Pipeline Products & Ongoing Clinical Trials Overview
Table 135: Biomarker Diagnostic Test - Rheumatoid Arthritis - Product Status
Table 136: Biomarker Diagnostic Test - Rheumatoid Arthritis - Product Description
Table 137: Protagen AG Pipeline Products & Ongoing Clinical Trials Overview
Table 138: Multilisa RA - Product Status
Table 139: Multilisa RA - Product Description
Table 140: NavigAID Rheumatoid Arthritis - Product Status
Table 141: NavigAID Rheumatoid Arthritis - Product Description
Table 142: Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview
Table 143: Biomarker Assay - Rheumatoid Arthritis - Product Status
Table 144: Biomarker Assay - Rheumatoid Arthritis - Product Description
Table 145: Research & Diagnostic Antibodies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 146: Diagnostic Test - Rheumatoid Arthritis - Product Status
Table 147: Diagnostic Test - Rheumatoid Arthritis - Product Description
Table 148: Selventa Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 149: Clarify - Rheumatoid Arthritis - Product Status
Table 150: Clarify - Rheumatoid Arthritis - Product Description
Table 151: SomaLogic Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 152: SOMAscan Assay - Rheumatoid Arthritis - Product Status
Table 153: SOMAscan Assay - Rheumatoid Arthritis - Product Description
Table 154: SQI Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 155: Ig_PLEX Rheumatoid Arthritis Panel With Expanded Markers - Product Status
Table 156: Ig_PLEX Rheumatoid Arthritis Panel With Expanded Markers - Product Description
Table 157: The Binding Site Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 158: Optilite - C-reactive Protein Test - Product Status
Table 159: Optilite - C-reactive Protein Test - Product Description
Table 160: Optilite - High Sensitive C-reactive Protein Kit - Product Status
Table 161: Optilite - High Sensitive C-reactive Protein Kit - Product Description
Table 162: Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 163: Phadia 2500 Laboratory System - RF IgM/IgA Test - Product Status
Table 164: Phadia 2500 Laboratory System - RF IgM/IgA Test - Product Description
Table 165: Phadia 5000 Laboratory System - CCP Test - Product Status
Table 166: Phadia 5000 Laboratory System - CCP Test - Product Description
Table 167: Phadia 5000 Laboratory System - RF IgM/IgA Test - Product Status
Table 168: Phadia 5000 Laboratory System - RF IgM/IgA Test - Product Description
Table 169: Toscana Biomarkers Srl Pipeline Products & Ongoing Clinical Trials Overview
Table 170: Diagnostic Assay - Rheumatoid Arthritis - Product Status
Table 171: Diagnostic Assay - Rheumatoid Arthritis - Product Description
Table 172: University Health Network Pipeline Products & Ongoing Clinical Trials Overview
Table 173: Biomarker Test - Rheumatoid Arthritis - Product Status
Table 174: Biomarker Test - Rheumatoid Arthritis - Product Description
Table 175: University of Aberdeen Pipeline Products & Ongoing Clinical Trials Overview
Table 176: Diagnostic Assay - Rheumatoid Arthritis - Product Status
Table 177: Diagnostic Assay - Rheumatoid Arthritis - Product Description
Table 178: University of Manchester Pipeline Products & Ongoing Clinical Trials Overview
Table 179: Molecular Pathology Test - Rheumatoid Arthritis - Product Status
Table 180: Molecular Pathology Test - Rheumatoid Arthritis - Product Description
Table 181: University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
Table 182: Biomarker Based Assay - Rheumatoid Arthritis - Product Status
Table 183: Biomarker Based Assay - Rheumatoid Arthritis - Product Description
Table 184: University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
Table 185: PBMC-Based Companion Diagnostic Test - Product Status
Table 186: PBMC-Based Companion Diagnostic Test - Product Description
Table 187: University of Warwick Pipeline Products & Ongoing Clinical Trials Overview
Table 188: Diagnostic Test - Arthritis - Product Status
Table 189: Diagnostic Test - Arthritis - Product Description
Table 190: University Rovira i Virgili Pipeline Products & Ongoing Clinical Trials Overview
Table 191: CD-Medics Test - RA - Product Status
Table 192: CD-Medics Test - RA - Product Description
Table 193: Glossary
1.2 List of Figures
Figure 1: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Stage of Development
Figure 2: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Segment
Figure 3: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Territory
Figure 4: Rheumatoid - Inflammatory Disea

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report